Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population

Vaccine

Volumn 19, Issue 32, 2001, Pages 4610-4617

  Gardner, Elizabeth M ^a   Bernstein, Erica D ^a   Dran, Sandra ^b   Munk, Gary ^b   Gross, Peter ^b   Abrutyn, Elias ^a   Murasko, Donna M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Elderly; Humoral; Influenza vaccination

Indexed keywords

A TEXAS ANTIBODY; ANTIBODY; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INFLUENZA VACCINATION; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL;

AGED; ANTIBODIES, VIRAL; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; SEROTYPING; VACCINATION;

EID: 0035860574     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00246-8     Document Type: Article

References (40)

1. The impact of influenza on mortality in the USA
2. Infections in older patients: A systematic clinical approach
3. Influenza and pneumococcal vaccination coverage among persons ≥ 65 years
4. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
5. Determinants of immunity to influenza infection in man
6. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
7. Influenza vaccines: The effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature
8. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial
9. Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and trivalent A/USSR/77 (H1N1)-A/Texas/77 (H3N2)-B/Hong Kong/72 vaccines
10. Risks for influenza and respiratory illness in vaccinated elderly
11. Relation of chronic disease and immune response to influenza vaccine in the elderly
12. Immune response to influenza vaccination in a large healthy elderly population
13. Cytokine production after influenza vaccination in a healthy elderly population
14. Immune response to influenza vaccination in healthy elderly: Lack of association with plasma β-carotene, retinol, α-tocopherol, or zinc
15. Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response
16. A graded dose study of inactivated surface antigen influenza B vaccine in volunteers
17. Failure of influenza vaccination in the aged
18. Immunization of elderly people with high doses of influenza vaccine
19. Antibody induction by influenza vaccines in the elderly: A review of the literature
20. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza-A at Christ's Hospital
21. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
22. Annual influenza vaccination: Immune response in patients over 10 years
23. HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992
24. Suppression of antibody formation by passively administered antibody
25. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period
26. Efficacy of sequential annual vaccination with inactivated influenza virus vaccines
27. Influenza vaccination and mortality from bronchopneumonia in the elderly
28. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people
29. Protection against influenza after annually repeated vaccination: A meta-analysis of serologic and field studies
30. Effect of influenza vaccines in stimulating antibody in volunteers with prior immunity
31. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial
32. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly
33. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination
34. Influenza viruses
35. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing
36. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine
37. Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: Effects of aging and 'original antigenic sin'
38. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak